Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot

episode

Scott Nelson Live not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Scott Nelson Live

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec 57 min · 16 Dec 2025

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD 52 min · 10 Dec 2025

All episodes from Scott Nelson Live →

Report any issue

Source

Recorded22 Jul 2020

Publisherfeeds.transistor.fm ↗

Handlerec:13866376

Show notes

In this episode of Medsider Radio, our guest is Matthew Amsden, the Founder, and CEO of ProofPilot, a platform designed to help people design, launch and participate in clinical trials.ProofPilot’s mission statement revolves around making it incredibly easy to run scientifically-valid research studies. They’re dedicated to making research study participation accessible, interesting, and fun. In this discussion with Matthew, we chatted about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.Interview Highlights with Matthew AmsdenWho is Matthew Amsden and where did the idea for ProofPilot begin? The importance of letting early customers try product iterations.How clinical studies can become a revenue driver. Various types of clinical trials and how they’re conducted on the ProofPilot platform.Risky and costly approaches to traditional clinical studies. The synergy between data, compliance, and incentives.How a virtual, hybrid model can solve problems when it comes to traditional clinical trials. Matthew’s favorite business book, the mentor he most admires, and the advice he’d give to his 30-year-old self.See more...

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.